GSA Capital Partners’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
NCM
6CM
PFCS
VCM
CCM
GCGM
DMC
MC
WP
GSA Capital Partners's GUTS Position: Q1 2026 in Review
GSA Capital Partners reduced its Fractyl Health (GUTS) stake by 54% in Q1 2026, selling an estimated $93.8K and leaving 87,465 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.
GSA Capital Partners first reported a position in GUTS in Q3 2025 and has held it in 3 quarters since. The position peaked at $416K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.
- GSA Capital Partners held 87,465 shares of Fractyl Health worth $40K as of Q1 2026.
- GSA Capital Partners sold 101,711 Fractyl Health shares in Q1 2026, an estimated $93.8K.
- Fractyl Health made up ﹤0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1619 holding.
- GSA Capital Partners first reported a position in Fractyl Health in Q3 2025 and has held it in 3 quarters since.
- GSA Capital Partners's Fractyl Health position peaked at $416K in Q4 2025.
- 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.